Budicort ER

Budesonide (Tablet) ·Incepta Pharmaceuticals Ltd.·Tablet (Extended Release)

0 views 0 reviews

Packages & prices

Pack	Price	Details
Unit Price	৳ 900.00	Unit Price: ৳ 30.00 (3 x 10: ৳ 900.00)

Administration

Adult: One 9 mg Budesonide extend release tablet should be taken once daily in the morning with or without food for up to 8 weeks or as prescribed by the doctor.

Use in children: Safety and effectiveness of budesonide in pediatric patients have not been established.

Use in Hepatic Impaired patients: Monitor patients for signs and/or symptoms of hypercorticism.

Effects

Common side effects are headache, nausea, upper abdominal pain, fatigue, acne, flatulence, joint pain, urinary tract infection, abdominal distension, constipation.

Indications

Budicort ER tablet is a glucocorticoid indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis.

Pharmacology

Budesonide is a synthetic corticosteroid having potent glucocorticoid activity and weak mineralocorticoid activity. It has approximately 200-fold higher affinity for the glucocorticoid receptor than cortisol and 15-fold than prednisolone. Budesonide is effective against inflammatory bowel diseases. It reduces inflammation of colon and also helps heal the lining of the colon.

Precautions

Since Budicort ER is a glucocorticoid, general warnings concerning glucocorticoids should be followed.
Risk of impaired adrenal function when transferring from glucocorticoid treatment with higher systemic effects to glucocorticoid treatment with lower systemic effects, such as Budicort ER. Taper patients slowly from systemic corticosteroids if transferring to Budicort ER.
Potential worsening of infections (e.g., chickenpox, measles, existing tuberculosis, fungal, bacterial, viral, or parasitic infection). Use with caution in patients with these infections.
Reduced liver function affects the elimination of glucocorticoid, and increases systemic availability of oral Budicort ER.